ASTRAZENECA PHARMA IND LT significantly underperformed on Friday. It returned -1.47% to close at 1600.3. It is currently trading +72% above it's 52 week low of 927.55 and is down only -15% from it's 52 week high.
ASTRAZEN is currently in a up trend. The previous long signal in ASTRAZEN has not been profitable for investors in general. If you are invested in ASTRAZEN at current levels please make sure that your allocation is limited and that your portfolio is well diversified.
During the last three months ASTRAZEN was mostly loss making and delivered on average -0.06% per day. It's best return during this period (of +6.59%) was on Thursday, 10 Jan, 2019. While it's worst loss in the same period (of -7.66%) was on Monday, 26 Nov, 2018. There was initially a bearish trend during this period which started on 16 Nov, 2018 and went on till 26 Nov, 2018. The trend delivered -19.48% losses to investors. This was followed by a bullish trend that started on 17 Dec, 2018 and ended on 21 Dec, 2018. This bullish trend delivered +6.13% to investors.
On monthly basis, ASTRAZEN delivered profits in more months over the last year, than losses. ASTRAZEN delivered profits in more months than NIFTY-50 index. ASTRAZEN significantly outperformed NIFTY-50 index in Aug 2018, when it returned +23.56% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. ASTRAZEN had a longer winning streak of profitable months than NIFTY-50 index. It went up in 5 straight months (from Apr 2018 to Aug 2018) during which period it delivered +75.02%. It is interesting to note that both ASTRAZEN and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.
"Behind every stock is a company. Find out what It's doing.
ASTRAZEN is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant fall in ASTRAZEN's volatility from 19 Oct, 2018 to 12 Nov, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.
Advanced/professional short-term investors should note that ASTRAZEN has significant negative skewness in it's return distribution. This indicates that ASTRAZEN is very risky for short-term investment and can significantly underperform for long durations.
NIFTY-50 index has more chance of extreme outcomes than ASTRAZEN. Therefore, NIFTY-50 must receive a lower allocation than ASTRAZEN in your portfolio. NIFTY-50 index usually has shorter drawdown period than ASTRAZEN.
On a general note (since you are interested in ASTRAZEN), three instruments that have performed similar to ASTRAZEN are CONCOR, ATULAUTO and LALPATHLAB. They must all be evaluated as alternative investment options and for diversification.
... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.
All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.
We want to empower investors with all the tools and analysis required by them to make a rational investment decision.If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute